(Q44399078)

2 December 2017

Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. (English)

1 reference

therapy-related acute myeloid leukemia

2 December 2017

0 references

author name string

N Kröger

1

1 reference

2 December 2017

R Brand

2

1 reference

2 December 2017

A van Biezen

3

1 reference

2 December 2017

J-Y Cahn

4

1 reference

2 December 2017

S Slavin

5

1 reference

2 December 2017

D Blaise

6

1 reference

2 December 2017

J Sierra

7

1 reference

2 December 2017

A Zander

8

1 reference

2 December 2017

D Niederwieser

9

1 reference

2 December 2017

T de Witte

10

1 reference

2 December 2017

Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

11

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Bone Marrow Transplantation

2 December 2017

1 reference

2 December 2017

37

1 reference

2 December 2017

2

1 reference

2 December 2017

183-189

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705226

2 December 2017

0 references

cites work

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Secondary leukemias induced by topoisomerase-targeted drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

13-cis retinoic acid treatment for myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Treatment of therapy-related leukemia and myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Prognosis in therapy-related acute myeloid leukemia and impact of karyotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705226

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705226

1 reference

2 December 2017

1 reference